ProToxNet: Expression-Aware Proteome-Wide Binding for Tissue-Stratified Adverse Event Prediction
ProToxNet is a novel framework that integrates proteome-wide drug–protein binding predictions with tissue-specific gene expression to accurately predict tissue-stratified adverse events for both known and novel drugs, demonstrating strong generalization and clinical validity across multiple benchmarks.